Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/3846
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAPRAHAMIAN, Ivan-
dc.contributor.authorMARTINELLI, Jose Eduardo-
dc.contributor.authorCECATO, Juliana-
dc.contributor.authorIZBICKI, Rafael-
dc.contributor.authorYASSUDA, Monica Sanches-
dc.date.accessioned2013-12-18T16:33:51Z-
dc.date.available2013-12-18T16:33:51Z-
dc.date.issued2011-
dc.identifier.citationINTERNATIONAL PSYCHOGERIATRICS, v.23, n.1, p.96-101, 2011-
dc.identifier.issn1041-6102-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/3846-
dc.description.abstractBackground: The Cambridge Cognitive Examination (CAMCOG) is a useful test in screening for Alzheimer's disease (AD). However, the interpretation of CAMCOG cut-off scores is problematic and reference values are needed for different educational strata. Given the importance of earlier diagnoses of mild dementia, new cut-off values are required which take into account patients with low levels of education. This study aims to evaluate whether the CAMCOG can be used as an accurate screening test among AD patients and normal controls with different educational levels. Methods: Cross-sectional assessment was undertaken of 113 AD and 208 elderly controls with heterogeneous educational levels (group 1: 1-4 years; group 2: 5-8 years; and group 3: >= 9 years) from a geriatric clinic. submitted to a thorough diagnostic evaluation for AD including the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX). Controls had no cognitive or mood complaints. Sensitivity (SE) and specificity (SP) for the CAMCOG in each educational group was assessed with receiver-operator-characteristic (ROC) curves. Results: CAMCOG mean values were lower when education was reduced in both diagnostic groups (controls - group 1: 87; group 2: 91; group 3: 96; AD - group 1: 63; group 2: 62; group 3: 77). Cutoff scores for the three education groups were 79, 80 and 90, respectively. SE and SP varied among the groups (group 1: 88.1% and 83.5%; group 2: 84.6% and 96%; group 3: 70.8% and 90%). Conclusion: The CAMCOG can be used as a cognitive test for patients with low educational level with good accuracy. Patients with higher education showed lower scores than previously reported.-
dc.language.isoeng-
dc.publisherCAMBRIDGE UNIV PRESS-
dc.relation.ispartofInternational Psychogeriatrics-
dc.relation.isreferencedbyhttp://dspace.fm.usp.br/handle/OPI/1157-
dc.rightsrestrictedAccess-
dc.subjectCAMCOG-
dc.subjectCAMDEX-
dc.subjectAlzheimer's disease-
dc.subjectscreening-
dc.subjecteducation-
dc.subject.otherCONCISE NEUROPSYCHOLOGICAL TEST-
dc.subject.otherELDERLY POPULATION-SAMPLE-
dc.subject.otherCOMMUNITY SAMPLE-
dc.subject.otherSAO-PAULO-
dc.subject.otherDEMENTIA-
dc.subject.otherDIAGNOSIS-
dc.subject.otherPERFORMANCE-
dc.subject.otherPREVALENCE-
dc.subject.otherLITERATE-
dc.subject.otherBRAZIL-
dc.titleCan the CAMCOG be a good cognitive test for patients with Alzheimer's disease with low levels of education?-
dc.typearticle-
dc.rights.holderCopyright CAMBRIDGE UNIV PRESS-
dc.description.notesThis article received a commentary (DOI 10.1017/S1041610212000385) and was replied by the authors at http://dspace.fm.usp.br/handle/OPI/1157-
dc.identifier.doi10.1017/S104161021000116X-
dc.identifier.pmid20678300-
dc.subject.wosPsychology, Clinical-
dc.subject.wosGeriatrics & Gerontology-
dc.subject.wosGerontology-
dc.subject.wosPsychiatry-
dc.subject.wosPsychology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalMARTINELLI, Jose Eduardo:Jundiai Med Sch, Div Geriatr, Jundiai, Brazil-
hcfmusp.author.externalCECATO, Juliana:Jundiai Med Sch, Div Geriatr, Jundiai, Brazil-
hcfmusp.author.externalIZBICKI, Rafael:Univ Sao Paulo, Fac Med, Inst Psychiat, BR-05403010 Sao Paulo, Brazil-
hcfmusp.author.externalYASSUDA, Monica Sanches:Sch Arts Sci & Humanities, Gerontol Div, Sao Paulo, Brazil-
hcfmusp.description.beginpage96-
hcfmusp.description.endpage101-
hcfmusp.description.issue1-
hcfmusp.description.volume23-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-79951681426-
hcfmusp.origem.idWOS:000285471900011-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAmerican Psychiatric Association, 1994, DIAGN STAT MAN MENT-
hcfmusp.relation.referenceAprahamian I, 2010, INT PSYCHOGERIATR, V22, P64, DOI 10.1017/S1041610209991141-
hcfmusp.relation.referenceAthey RJ, 2006, INT J GERIATR PSYCH, V21, P977, DOI 10.1002/gps.1595-
hcfmusp.relation.referenceBallard CG, 1999, DEMENT GERIATR COGN, V10, P104, DOI 10.1159/000017109-
hcfmusp.relation.referenceBottino CMC, 2001, ARQ NEURO-PSIQUIAT, V59, P20-
hcfmusp.relation.referenceBottino CMC, 2008, DEMENT GERIATR COGN, V26, P291, DOI 10.1159/000161053-
hcfmusp.relation.referenceBrucki SMD, 2008, ARCH CLIN NEUROPSYCH, V23, P139, DOI 10.1016/j.acn.2007.11.003-
hcfmusp.relation.referenceBrucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014-
hcfmusp.relation.referenceCullum S, 2000, INT J GERIATR PSYCH, V15, P853, DOI 10.1002/1099-1166(200009)15:9<853::AID-GPS211>3.3.CO;2-K-
hcfmusp.relation.referencede Koning I, 2000, STROKE, V31, P1502-
hcfmusp.relation.referenceHototian SR, 2008, DEMENT GERIATR COGN, V25, P135, DOI 10.1159/000112554-
hcfmusp.relation.referenceHUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529-
hcfmusp.relation.referenceKATZMAN R, 1993, NEUROLOGY, V43, P13-
hcfmusp.relation.referenceLARKS J, 2007, CAD SAUDE PUBLICA, V23, P315-
hcfmusp.relation.referenceLourenco RA, 2008, REV BRAS PSIQUIATR, V30, P309, DOI 10.1590/S1516-44462008000400002-
hcfmusp.relation.referenceMCKHANN G, 1984, NEUROLOGY, V34, P939-
hcfmusp.relation.referenceMorais J, 2000, BRAIN COGNITION, V42, P47, DOI 10.1006/brcg.1999.1158-
hcfmusp.relation.referenceMoreira IDH, 2009, CAD SAUDE PUBLICA, V25, P1774, DOI 10.1590/S0102-311X2009000800013-
hcfmusp.relation.referenceMORRIS JC, 1995, TREATING ALZHEIMERS-
hcfmusp.relation.referenceNeri AL, 2007, IDOSOS BRASIL VIVENC-
hcfmusp.relation.referenceNielsen H, 1999, INT J GERIATR PSYCH, V14, P957, DOI 10.1002/(SICI)1099-1166(199911)14:11<957::AID-GPS43>3.0.CO;2-B-
hcfmusp.relation.referenceNitrini R, 2004, J INT NEUROPSYCH SOC, V10, P634, DOI 10.1017/S1355617704104062-
hcfmusp.relation.referenceNunes PV, 2008, INT J GERIATR PSYCH, V23, P1127, DOI 10.1002/gps.2038-
hcfmusp.relation.referenceParadela EMP, 2009, ARQ NEURO-PSIQUIAT, V67, P439, DOI 10.1590/S0004-282X2009000300013-
hcfmusp.relation.referencePetersson KM, 2001, SCAND J PSYCHOL, V42, P251, DOI 10.1111/1467-9450.00235-
hcfmusp.relation.referenceROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698-
hcfmusp.relation.referenceSchmand B, 2000, PSYCHOL MED, V30, P619, DOI 10.1017/S0033291799002068-
hcfmusp.relation.referenceWilliams JG, 2003, INT J GERIATR PSYCH, V18, P631, DOI 10.1002/gps.886-
hcfmusp.relation.referenceYassuda MS, 2009, ARCH CLIN NEUROPSYCH, V24, P71, DOI 10.1093/arclin/acp009-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus19-
hcfmusp.scopus.lastupdate2022-09-16-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/Outros
Outros departamentos - FM/Outros

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - LIM/27
LIM/27 - Laboratório de Neurociências


Files in This Item:
File Description SizeFormat 
art_APRAHAMIAN_The_CAMCOG_for_patients_with_Alzheimer_s_disease_2011.PDF
  Restricted Access
publishedVersion (English)128 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.